Schedule 13G ownership disclosure
Aura Biosciences Inc
Common Stock · CUSIP: 05153U107
Event date: 2024-12-24
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- LONG FOCUS CAPITAL MANAGEMENT, LLC
Shares: 2,507,774.00 · Class: 3.6%
- LONG FOCUS CAPITAL MASTER, LTD.
Shares: 1,782,997.00 · Class: 3.6%
- CONDAGUA, LLC
Shares: 724,777.00 · Class: 1.4%
- JOHN HELMERS
Shares: 2,507,774.00 · Class: 5.7%
- GLENN HELMERS
Shares: 724,777.00 · Class: 1.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001019056-25-000005
- Form type
- SCHEDULE 13G
- Filer
- Aura Biosciences, Inc.
- CIK
- CIK 1501796
- Filed
- Jan 03, 2025
- Reporting period
- Dec 24, 2024
- Description
- Schedule 13G beneficial ownership